Home > Cashflow Statement > KILITCH DRUGS (INDIA)

KILITCH DRUGS (INDIA)
Cashflow Statement

KILITCH DRUGS (INDIA) is part of below Screeners ↓
Top Undervalued Small Cap Stocks
COMMUNITY POLL
for KILITCH DRUGS (INDIA)
Please provide your vote to see the results

KILITCH DRUGS (INDIA) Last 5 Year Cashflow Statement History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
Profit Before Tax₹34 Cr₹19 Cr₹12 Cr₹9.61 Cr₹5.12 Cr
Adjustment ₹1.16 Cr₹10 Cr₹9.79 Cr₹3.89 Cr₹2.80 Cr
Changes In working Capital ₹-9.63 Cr₹-24 Cr₹-15 Cr₹-5.19 Cr₹39 Cr
Cash Flow after changes in Working Capital ₹26 Cr₹5.50 Cr₹6.92 Cr₹8.32 Cr₹47 Cr
Cash Flow from Operating Activities ₹18 Cr₹-1.53 Cr₹2.59 Cr₹5.78 Cr₹46 Cr
Cash Flow from Investing Activities ₹-40 Cr₹-8.16 Cr₹7.92 Cr₹-15 Cr₹-38 Cr
Cash Flow from Financing Activities ₹13 Cr₹8.81 Cr₹-0.72 Cr₹7.03 Cr₹1.61 Cr
Net Cash Inflow / Outflow ₹-9.16 Cr₹-0.88 Cr₹9.78 Cr₹-2.44 Cr₹9.70 Cr
Opening Cash & Cash Equivalents ₹19 Cr₹20 Cr₹10 Cr₹13 Cr₹2.80 Cr
Cash & Cash Equivalent on Amalgamation / Take over / Merger -----
Cash & Cash Equivalent of Subsidiaries under liquidations -----
Translation adjustment on reserves / op cash balalces frgn subsidiaries -----
Effect of Foreign Exchange Fluctuations -----
Closing Cash & Cash Equivalent ₹9.80 Cr₹19 Cr₹20 Cr₹10 Cr₹13 Cr

Compare Cashflow Statement of peers of KILITCH DRUGS (INDIA)

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
KILITCH DRUGS (INDIA) ₹587.1 Cr -2.7% -0.5% 9.6% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹401,541.0 Cr -3.6% -6.8% -5.6% Stock Analytics
DIVIS LABORATORIES ₹163,031.0 Cr -5.4% -2.4% 3.9% Stock Analytics
TORRENT PHARMACEUTICALS ₹138,451.0 Cr 3.6% 8.5% 23.5% Stock Analytics
CIPLA ₹112,377.0 Cr -5.1% -7.1% -3.5% Stock Analytics
DR REDDYS LABORATORIES ₹97,355.5 Cr -4.1% -8.3% -12.1% Stock Analytics


KILITCH DRUGS (INDIA) Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
KILITCH DRUGS (INDIA)

-2.7%

-0.5%

9.6%

SENSEX

-0.4%

-1.7%

9.1%


You may also like the below Video Courses